Upstream Bio, Inc. (UPB)
2.74
-0.25
(-8.36%)
USD |
NASDAQ |
Oct 23, 16:00
2.735
0.00 (0.00%)
After-Hours: 20:00
Upstream Bio Price : 2.74 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 2.95 | 2.96 | 2.695 | 2.74 | 1.051M |
| Oct 22, 2026 | 2.77 | 2.99 | 2.70 | 2.99 | 1.450M |
| Oct 21, 2026 | 2.83 | 2.975 | 2.765 | 2.80 | 1.410M |
| Oct 20, 2026 | 2.79 | 3.09 | 2.78 | 2.82 | 1.676M |
| Oct 19, 2026 | 2.76 | 3.07 | 2.75 | 2.80 | 1.604M |
| Oct 16, 2026 | 3.39 | 3.39 | 2.74 | 2.76 | 1.836M |
| Oct 15, 2026 | 3.44 | 3.555 | 3.285 | 3.37 | 1.285M |
| Oct 14, 2026 | 3.475 | 3.60 | 3.29 | 3.42 | 1.574M |
| Oct 13, 2026 | 4.14 | 4.155 | 3.52 | 3.55 | 1.038M |
| Oct 12, 2026 | 4.68 | 4.72 | 4.12 | 4.17 | 848408.0 |
| Oct 09, 2026 | 4.54 | 4.76 | 4.51 | 4.70 | 1.188M |
| Oct 08, 2026 | 4.53 | 4.65 | 4.365 | 4.55 | 2.857M |
| Oct 07, 2026 | 4.55 | 4.72 | 4.50 | 4.61 | 908403.0 |
| Oct 06, 2026 | 4.84 | 4.865 | 4.53 | 4.59 | 1.062M |
| Oct 05, 2026 | 5.07 | 5.10 | 4.665 | 4.85 | 1.011M |
| Oct 02, 2026 | 5.12 | 5.21 | 4.86 | 5.04 | 956520.0 |
| Oct 01, 2026 | 5.25 | 5.345 | 4.98 | 5.04 | 832378.0 |
| Sep 30, 2026 | 5.23 | 5.455 | 5.145 | 5.27 | 851222.0 |
| Sep 29, 2026 | 5.28 | 5.305 | 4.99 | 5.19 | 784211.0 |
| Sep 28, 2026 | 5.34 | 5.385 | 5.12 | 5.30 | 615403.0 |
| Sep 25, 2026 | 5.20 | 5.39 | 5.07 | 5.36 | 429212.0 |
| Sep 24, 2026 | 5.19 | 5.20 | 5.045 | 5.17 | 566581.0 |
| Sep 23, 2026 | 5.48 | 5.49 | 4.985 | 5.19 | 552994.0 |
| Sep 22, 2026 | 5.44 | 5.56 | 5.38 | 5.49 | 360533.0 |
| Sep 21, 2026 | 5.42 | 5.44 | 5.27 | 5.365 | 364035.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Sutro Biopharma, Inc. | 9.33 |
| ACADIA Pharmaceuticals, Inc. | 19.73 |
| Alnylam Pharmaceuticals, Inc. | 224.03 |
| Anika Therapeutics, Inc. | 21.42 |
| Savara, Inc. | 4.22 |
Price Related Metrics
| PS Ratio | 47.08 |
| PEG Ratio | -0.0233 |
| Price to Book Value | 0.5539 |
| Earnings Yield | -105.3% |
| Market Cap | 150.07M |
| PEGY Ratio | -0.0233 |